Hudson Bay Capital Management LP Sells 50,000 Shares of Oaktree Acquisition Corp. III Life Sciences $OACC

Hudson Bay Capital Management LP reduced its position in Oaktree Acquisition Corp. III Life Sciences (NASDAQ:OACC) by 11.1% during the second quarter, HoldingsChannel reports. The firm owned 400,000 shares of the company’s stock after selling 50,000 shares during the period. Hudson Bay Capital Management LP’s holdings in Oaktree Acquisition Corp. III Life Sciences were worth $4,192,000 at the end of the most recent quarter.

Several other large investors also recently modified their holdings of OACC. Driehaus Capital Management LLC acquired a new position in Oaktree Acquisition Corp. III Life Sciences in the first quarter valued at $9,180,000. Linden Advisors LP bought a new position in shares of Oaktree Acquisition Corp. III Life Sciences in the 1st quarter worth about $6,120,000. Goldman Sachs Group Inc. acquired a new position in shares of Oaktree Acquisition Corp. III Life Sciences in the 1st quarter valued at about $5,417,000. Moore Capital Management LP bought a new stake in shares of Oaktree Acquisition Corp. III Life Sciences during the 2nd quarter valued at about $5,502,000. Finally, Alberta Investment Management Corp acquired a new stake in Oaktree Acquisition Corp. III Life Sciences during the second quarter worth approximately $5,240,000.

Analysts Set New Price Targets

Separately, Weiss Ratings reissued a “sell (d-)” rating on shares of Oaktree Acquisition Corp. III Life Sciences in a research note on Wednesday, October 8th. One research analyst has rated the stock with a Sell rating, According to MarketBeat.com, the company has a consensus rating of “Sell”.

Oaktree Acquisition Corp. III Life Sciences Stock Up 0.2%

Oaktree Acquisition Corp. III Life Sciences stock opened at $10.60 on Tuesday. The firm’s fifty day moving average price is $10.58 and its two-hundred day moving average price is $10.51. Oaktree Acquisition Corp. III Life Sciences has a 1-year low of $9.95 and a 1-year high of $10.85.

Oaktree Acquisition Corp. III Life Sciences Company Profile

Oaktree Acquisition Corp. III Life Sciences is a blank check company, which was created for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. The company was founded in 1995 and is headquartered in Los Angeles, CA.